Sage Journals: Discover world-class research

Abstract

Objective

Obesity is a strong and independent factor for the development of atrial fibrillation (AF), and adversely impacts the success of catheter ablation procedures for AF. This study evaluated the impact of body mass index (BMI) on the outcomes following surgical ablation of AF.

Methods

Between 2003 and 2019, 236 patients underwent a stand-alone biatrial Cox maze IV procedure (CMP-IV) for refractory AF. Obesity was defined as BMI ≥30 kg/m². Patients were divided into two groups: BMI <30 kg/m² (n = 100) and BMI ≥30 kg/m² (n = 136). Freedom from atrial tachyarrhythmia (ATA) was determined using electrocardiography, Holter, or pacemaker interrogation at 1 year and annually thereafter. Recurrence was defined as any documented ATA lasting ≥30 s. Predictors of recurrence were determined using multivariable logistic regression. Preoperative and procedural outcomes were compared between groups.

Results

Obese patients had a higher rate of diabetes (16% vs 7%, P = 0.044) and larger left atrial diameter (4.9 ± 1.1 cm vs 4.6 ± 1.0 cm, P = 0.021) when compared to non-obese patients. There was no difference in major complication rate between the groups (4% vs 7%, P = 0.389). There was no operative mortality in either group. During 4.1 ± 2.4 years of follow-up, there was no significant difference in freedom from ATA with or without antiarrhythmic drugs in obese patients when compared to the non-obese group (P > 0.05). Absence of sinus rhythm at discharge predicted AF recurrence up to 7 years postoperatively.

Conclusions

As opposed to catheter ablation, obesity did not adversely impact the short and long-term outcomes of stand-alone surgical ablation with CMP-IV, and BMI was not a predictor of AF recurrence. Additionally, there was no significant increase in major complications in obese patients.

Keywords

atrial fibrillation surgical ablation catheter ablation obesity

Get full access to this article

View all access options for this article.

References

Morillo

CA.

Banerjee

Perel

et al. Atrial fibrillation: the current epidemic. J Geriatr Cardiol 2017; 14: 195–203.28592963

Wanahita

Messerli

FH.

Bangalore

et al. Atrial fibrillation and obesity – results of a meta-analysis. Am Heart J 2008; 155: 310–315.18215602

Wang

TJ.

Parise

Levy

et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004; 292: 2471–2477.15562125

Gami

AS.

Hodge

DO.

Herges

et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007; 49: 565–571.17276180

Murphy

NF.

MacIntyre

Stewart

et al. Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J 2006; 27: 96–106.16183687

Yorgun

Canpolat

Aytemir

et al. Association of epicardial and peri-atrial adiposity with the presence and severity of non-valvular atrial fibrillation. Int J Cardiovasc Imaging 2015; 31: 649–657.25466809

Abed

HS.

Samuel

CS.

Lau

et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm 2013; 10: 90–100.23063864

Marrouche

NF.

Wilber

Hindricks

et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA 2014; 311: 498–506.24496537

Mariscalco

Wozniak

MJ.

Dawson

et al. Body mass index and mortality among adults undergoing cardiac surgery: a nationwide study with a systematic review and meta-analysis. Circulation 2017; 135: 850–863.28034901

10.

Bunch

TJ.

May

HT.

Bair

et al. Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation. J Interv Card Electrophysiol 2016; 46: 259–265.27207256

11.

Winkle

RA.

Mead

RH.

Engel

et al. Impact of obesity on atrial fibrillation ablation: patient characteristics, long-term outcomes, and complications. Heart Rhythm 2017; 14: 819–827.28232261

12.

Chilukuri

Dalal

Gadrey

et al. A prospective study evaluating the role of obesity and obstructive sleep apnea for outcomes after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2010; 21: 521–525.19925607

13.

Sivasambu

Balouch

MA.

Zghaib

et al. Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients. J Cardiovasc Electrophysiol 2018; 29: 239–245.29131442

14.

De Maat

GE.

Mulder

BA.

Berretty

et al. Obesity is associated with impaired long-term success of pulmonary vein isolation: a plea for risk factor management before ablation. Open Heart 2018; 5: e000771.29862033

15.

Wong

CX.

Sullivan

Sun

et al. Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC Clin Electrophysiol 2015; 1: 139–152.29759357

16.

Ruaengsri

Schill

MR.

Khiabani

et al. The Cox-maze IV procedure in its second decade: still the gold standard? Eur J Cardiothorac Surg 2018; 53(Suppl 1): i19–i25.29590383

17.

MacGregor

RM.

Khiabani

AJ.

Damiano

. The surgical treatment of atrial fibrillation via median sternotomy. Oper Tech Thorac Cardiovasc Surg 2019; 24: 19–37.

18.

Calkins

Hindricks

Cappato

et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2017; 14: e275–e444.28506916

19.

Henn

MC.

Lancaster

TS.

Miller

et al. Late outcomes after the Cox maze IV procedure for atrial fibrillation. J Thorac Cardiovasc Surg 2015; 150: 1168–1178.26432719

20.

Pet

Robertson

JO.

Bailey

et al. The impact of CHADS₂ score on late stroke after the Cox maze procedure. J Thorac Cardiovasc Surg 2013; 146: 85–89.22818126

21.

Pathak

RK.

Middeldorp

ME.

Meredith

et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol 2015; 65: 2159–2169.25792361

22.

Middeldorp

ME.

Pathak

RK.

Meredith

et al. Prevention and regressive effect of weight-loss and risk factor modification on atrial fibrillation: the REVERSE-AF study. Europace 2018; 20: 1929–1935.29912366

23.

Mohanty

Di Biase

et al. Influence of body mass index on quality of life in atrial fibrillation patients undergoing catheter ablation. Heart Rhythm 2011; 8: 1847–1852.21740879

24.

Cha

Y-M.

Friedman

PA.

Asirvatham

et al. Catheter ablation for atrial fibrillation in patients with obesity. Circulation 2008; 117: 2583–2590.18474813

25.

Guijian

Jinchuan

Rongzeng

et al. Impact of body mass index on atrial fibrillation recurrence: a meta-analysis of observational studies. Pacing Clin Electrophysiol 2013; 36: 748–756.23437987

26.

Jin

Grunkemeier

GL.

Furnary

et al. Is obesity a risk factor for mortality in coronary artery bypass surgery? Circulation 2005; 111: 3359–3365.15967852

27.

Schwann

TA.

Habib

RH.

Zacharias

et al. Effects of body size on operative, intermediate, and long-term outcomes after coronary artery bypass operation. Ann Thorac Surg 2001; 71: 521–530.11235700

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.10 MB

0.09 MB

0.27 MB